How Boehringer Ingelheim is buttressing its US business

How Boehringer Ingelheim is buttressing its U...

Up next

Boston, China and the future of biotech

Boston remains biotech's most influential hub, but the questions facing the region are increasingly global. Recorded live at Fierce Biotech Week in Boston, this panel discussion brings together Uli Stilz, senior advisor at Flagship Pioneering; Bruce Beutel, CEO and co-founder of ...  Show more

BioAge CEO talks NLRP3 and ‘pipeline in a pill’ ambitions

Recorded last week at Fierce Biotech Week in Boston, this episode of “The Top Line” features a conversation with Kristen Fortney, Ph.D., co-founder and CEO of BioAge Labs. In a conversation with Ayla Ellison, editor-in-chief of Fierce Healthcare and Life Sciences, Fortney discuss ...  Show more